This content is machine translated Advanced breast cancer Next-generation SERD therapy with promising results The results of the Phase III EMBER-3 trial of imlunestrant, a next-generation oral selective oestrogen receptor degrader (SERD) for patients with hormone receptor-positive breast cancer in ER-positive, HER2-negative advanced breast...…
View Post 3 min This content is machine translated Breast Cancer On the trail of triple-negative breast cancer Triple-negative breast cancer (TNBC) is a disease with an often aggressive course and a poor prognosis compared to other subtypes of breast cancer. It accounts for around 10-15% of all…
View Post 7 min This content is machine translated Breast Cancer News from the world of prevention, diagnosis and therapy Every year in December, around 7500 breast cancer experts from all over the world meet at the San Antonio Breast Cancer Symposium. The highlights of current breast cancer research on…
View Post 3 min This content is machine translated Breast Cancer HER2-negative breast cancer in a pot with triple-negative tumors? One study suggests that patients with low HR-positive/HER2-negative tumors could be considered and treated similarly to patients with triple-negative tumors. Should the current definitions of HR positivity and their clinical…
View Post 7 min This content is machine translated Hematology and medical oncology The world of hematology and oncology research The rapid technological developments in diagnostics and innovations in multimodal therapy in the field of hematology and medical oncology were the focus of the annual conference. While immunotherapies with monoclonal…
View Post 3 min This content is machine translated Breast Cancer From pathophysiology to new therapeutic strategies Breast cancer, the most common malignancy in women worldwide, is a very heterogeneous disease. The different molecular profiles can be divided into three main subtypes according to hormone receptor (ER…
View Post 6 min This content is machine translated Cancer Management Oncological interventions at the cutting edge of knowledge The latest findings in the field of cancer research were again presented at the ASCO Annual Meeting in Chicago. Experts discussed innovative treatment methods, new therapies and current controversies in…
View Post 4 min This content is machine translated Breast Cancer Improving treatment management: genetics in focus The genetics of breast cancer has become a fundamental aspect of treatment management. It influences screening, follow-up, prophylactic and therapeutic recommendations for women who carry a germinal breast cancer susceptibility…
View Post 6 min This content is machine translated Breast Cancer Latest findings around breast cancer research International experts have been meeting annually since 1977 to share current information on breast cancer research. The goal is to balance clinical, translational, and basic research and to provide a…
View Post 3 min This content is machine translated Virtual workshop series for breast cancer patients I do it for me! The diagnosis of breast cancer means a massive break in the lives of those affected and their relatives. Suddenly, the focus changes from the usual daily routine to fighting the…
View Post 3 min This content is machine translated Breast Cancer New options in advanced breast cancer While new lecture formats had to be established due to the Corona pandemic, substantial progress in research around cancer therapies remained constant, as evidenced by study results presented at EHA.…
